Smaller amygdala and medial prefrontal cortex predict escalating stimulant use.

Area of Science:

• Neuroscience
• Addiction Research
• Brain Imaging

Background:

• Drug addiction is a chronic brain disorder requiring early intervention strategies.
• Identifying biomarkers for vulnerability to escalating drug use is critical.

Purpose of the Study:

• To prospectively assess brain structural markers for escalating amphetamine-type stimulant (ATS) use.
• To identify individuals at risk for transitioning from occasional to problematic ATS use.

Main Methods:

• Structural brain imaging was used to assess grey matter volumes in occasional ATS users at baseline.
• Participants were followed up for 24 months to track changes in drug use.
• Baseline brain volumes were compared between those who increased use and those who maintained or reduced use.

Main Results:

• Participants who escalated ATS use showed smaller baseline volumes in the medial prefrontal cortex, basolateral amygdala, and dorsal striatum.
• Smaller baseline volumes in these regions negatively correlated with subsequent stimulant use over 12 and 24 months.
• Evidence suggests a compound-specific association between left basolateral amygdala volume and subsequent amphetamine use.

Conclusions:

• Reduced grey matter volume in fronto-striato-limbic regions is associated with vulnerability to escalating ATS use.
• These brain structural differences may indicate impaired impulsivity and decision-making, predisposing individuals to addiction.
• Findings support the potential for using brain imaging to identify individuals at risk for developing stimulant use disorder.